Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenous nitric oxide can control SIRS and downregulate NFkappaB.

Francisco S Lozano1, Marcello B Barros, Francisco J García-Criado

  • 1Department of Vascular Surgery, University Hospital, University of Salamanca, Salamanca, Spain.

The Journal of Surgical Research
|March 1, 2005
PubMed
Summary

Exogenous nitric oxide (NO) administration significantly reduced mortality in a two-insult model of Systemic Inflammatory Response Syndrome (SIRS). NO treatment also decreased key inflammatory markers at both biochemical and cellular levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance.

Frontiers in cell and developmental biology·2022
Same author

Corrigendum.

Pain medicine (Malden, Mass.)·2021
Same author

Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).

Trials·2021
Same author

Abdominal aortic aneurysm and acute appendicitis: a case report and review of the literature.

Journal of medical case reports·2021
Same author

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Frontiers in immunology·2020
Same author

Simple and complex carotid paragangliomas. Three decades of experience and literature review.

Head & neck·2020

Area of Science:

  • Immunology
  • Biochemistry
  • Physiology

Background:

  • Nitric oxide (NO) plays a crucial role in modulating inflammatory processes.
  • Experimental evidence suggests NO can mitigate Systemic Inflammatory Response Syndrome (SIRS).
  • This study investigates NO's effects on a dual-insult SIRS model.

Purpose of the Study:

  • To evaluate the therapeutic potential of exogenous NO in a rat model of SIRS.
  • To assess NO's impact on biochemical and cellular inflammatory markers.
  • To determine NO's effect on mortality rates in SIRS.

Main Methods:

  • A two-insult SIRS model was induced in Wistar rats via Dacron graft implantation and Zymosan A administration.
  • Animals were grouped into control (SIRS induction) and treatment (SIRS + NO) groups.

Related Experiment Videos

  • Key markers measured included survival, TNF-alpha, SOA, ICAM-1, and NFkappaB.

    • Main Results:

    • The control group exhibited a 20% mortality rate with elevated TNF-alpha, SOA, ICAM-1, and NFkappaB.
    • NO treatment reduced mortality to 0%.
    • NO significantly decreased TNF-alpha, SOA, ICAM-1 expression, and NFkappaB levels.

    Conclusions:

    • Exogenous NO effectively controlled SIRS at both biochemical and cellular levels.
    • NO administration demonstrated lasting control over inflammatory responses.
    • The study highlights NO's potential as a therapeutic agent for SIRS.